Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b–Literature Review and Personal Preliminary Experience

The inflammatory response to COVID-19 is specifically associated with an impaired type I interferon (IFN) response and complete blockade of IFN-β secretion. Clinically, nebulization of IFN-α-2b has been historically used in China to treat viral pneumonia associated with SARS-CoV. Very recent data sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Mary, Aurélien, Hénaut, Lucie, Macq, Pierre Yves, Badoux, Louise, Cappe, Arnaud, Porée, Thierry, Eckes, Myriam, Dupont, Hervé, Brazier, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734101/
https://www.ncbi.nlm.nih.gov/pubmed/33329000
http://dx.doi.org/10.3389/fphar.2020.592543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734101/
https://www.ncbi.nlm.nih.gov/pubmed/33329000
http://dx.doi.org/10.3389/fphar.2020.592543

Ejemplares similares